Compare PSNYW & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSNYW | SENS |
|---|---|---|
| Founded | 2017 | 1996 |
| Country | Sweden | United States |
| Employees | 2547 | N/A |
| Industry | Auto Manufacturing | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.4M | 252.5M |
| IPO Year | N/A | N/A |
| Metric | PSNYW | SENS |
|---|---|---|
| Price | $6.23 | $5.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $25.58 |
| AVG Volume (30 Days) | 43.4K | ★ 373.2K |
| Earning Date | 03-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,034,261,000.00 | $29,298,000.00 |
| Revenue This Year | N/A | $59.55 |
| Revenue Next Year | $79.49 | $70.49 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 31.94 |
| 52 Week Low | $0.09 | $5.25 |
| 52 Week High | $0.61 | $28.00 |
| Indicator | PSNYW | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 74.17 | 40.88 |
| Support Level | $5.07 | $6.03 |
| Resistance Level | $7.50 | $6.44 |
| Average True Range (ATR) | 0.94 | 0.35 |
| MACD | 0.28 | -0.15 |
| Stochastic Oscillator | 78.17 | 0.00 |
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.